A 60-year-old man with HIV presents for follow-up of HIV and hypertension. Three months ago, his blood pressure was 128/88 mm Hg. At that time, he initiated lifestyle changes. One week ago, his blood pressure was 137/85 mm Hg. At the current visit, his blood pressure is 134/86 mm Hg. He has several additional medical problems, including hyperlipidemia and gout; he does not have diabetes mellitus or renal disease. His medications are bictegravir-tenofovir alafenamide-emtricitabine and rosuvastatin. Using the atherosclerotic cardiovascular disease (ASCVD) risk calculator, his 10-year risk for heart disease and stroke is estimated at 12.8%.
Which one of the following is the best option for the management of hypertension in this man?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
January 27th, 2025
January 27th, 2025
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5
Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine Edurant